14Apr
M&A Litigation Rising Amidst COVID-19 Uncertainty: Considerations for Litigators and Deal-Makers
Just as no human being is naturally immune to the COVID-19 virus, no industry is immune to its economic effects—and related M&A activity across all industries proves no exception. In the weeks following the issuance of stay-at-home orders in states...
By:
White and Williams LLP
Related
On February 26, 2020, the National Labor Relations Board (the NLRB) issued its final rule governing ...
Read More >
On November 8, 2019, the Federal Trade Commission (“FTC”) and the Antitrust Division of the U.S. D...
Read More >
The COVID-19 pandemic is having a profound economic impact across the globe. Entire industries have ...
Read More >
It has been several years since the US Supreme Court issued a decision in a case involving the Emplo...
Read More >
On July 5, 2019, a Centers for Medicare & Medicaid Services (“CMS”) regulation (proposed by the Tr...
Read More >
The “20% Rule,” which provided guidance to employers for when they must pay tipped employees minim...
Read More >